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United States (2001-2006): A significant survival benefit over open
repair is independently associated with increased institutional volume
James McPhee, Mohammad H. Eslami, Elias J. Arous, Louis M. Messina,
Andres Schanzer
Objective: Endovascular aortic repair (EVAR) has gained wide acceptance
for the elective treatment of abdominal aortic aneurysms (AAA), leading
to interest in similar treatment of ruptured abdominal aortic aneurysms
(RAAA). The purpose of this study was to evaluate national outcomes
after EVAR for RAAA and to assess the effect of institutional volume
metrics.
Methods: The Nationwide Inpatient Sample was used to identify patients
treated with open or EVAR for RAAA, 2001-2006. Procedure volume was
determined for each institution categorizing hospitals as low-, medium-,
and high-volume. The primary outcome was in-hospital mortality. Secondary
outcomes related to resource utilization. Multivariable logistic regression
models were used to determine independent predictors of EVAR usage and
mortality.
Results: From 2001 to 2006, an estimated 27,750 hospital discharges for
RAAA occurred; 11.5% were treated with EVAR. EVAR utilization increased
over time (5.9% in 2001 to 18.9% in 2006, P < .0001) while overall RAAA rates
remained constant. EVAR had a lower overall in-hospital mortality than open
repair (31.7% vs 40.7%, P < .0001), an effect which amplified when stratified
by institutional volume. On multivariable regression, open repair indepen-
dently predicted mortality (odds ratio [OR] 1.56; 95% confidence interval
[CI] 1.29-1.89). EVAR usage for RAAA increased with age (>80 years) (OR
1.58; 95% CI 1.30-1.93), high elective EVAR volume (>40/y) vs medium
(19-40/y) (OR 2.65; 95% CI 1.86-3.78) and low (<19/y) (OR 5.37; 95% CI
3.60-8.0). EVAR had a shorter length of stay (11.1 vs 13.8 days, P < .0001),
higher discharges to home (65.1% vs 53.9%, P < .0001), and lower charges
($108,672 vs $114,784, P < .0001).
Conclusions: In the United States, for RAAA, EVAR had a lower postoper-
ative mortality than open repair. Higher elective open repair as well as
RAAA volume increased this mortality advantage for EVAR. These
results support regionalization of RAAA repair to high volume centers
whenever possible and a wider adoption of endovascular repair of RAAA
nationwide.The phase I multicenter trial (STAPLE-1) of the Aptus Endovascular Repair
System: Results at 6 months and 1 year
David H. Deaton, Manish Mehta, Karthik Kasirajan, Elliot Chaikof, Mark
Farber, Marc H. Glickman, Richard F. Neville, Ronald M. Fairman
Objective: This phase I IDE study (STAPLE-1) evaluated the primary
endpoints of safety (major device-related adverse events at 30 days) and
feasibility (successful deployment of all endograft components) of the Aptus
Endovascular abdominal aortic aneurysm (AAA) Repair System (Aptus Endo-
systems, Inc, Sunnyvale, Calif) to treat AAAs.
Methods: A prospective, single arm Federal Drug Administration (FDA) Phase
I IDE study was performed. The Aptus endograft is a three-piece modular
device with a flexible unsupported main body and two fully supported limbs* Full articles available online at www.jvascsurg.org
1078e5884/$36.00
doi:10.1016/S1078-5884(09)00083-5in a 5.3 mm outer diameter (OD) (16F) delivery system for all iliac limbs and
two of three main body sizes. The largest main body (29 mm diameter) is in
a 6 mm OD (18F) delivery system. EndoStaples measuring 4 mm (length) by 3
mm (diameter) designed to provide transmural graft fixation to the adven-
titia are applied independent of the endograft delivery system. Inclusion
criteria included a proximal aortic neck length of 12 mm and iliac landing
zone of 10 mm. Secondary endpoints included freedom from endoleaks,
rupture, migration, and device integrity.
Results: Twenty-one (21) patients were enrolled at five centers. All patients
received the Aptus Endograft and EndoStaples. Ninety-six EndoStaples
(range, 2-10; median, 4) were implanted. All patients (n = 21) completed
1-month and 6-month follow-up evaluation and 14 completed 1-year
follow-up. Two proximal cuffs and one limb extension were used as adjunc-
tive endograft components at implantation. Three secondary interventions
were performed in 2 patients for limb thrombosis. There were no Endo-
Staple-related adverse events, device integrity failures, migrations, or
conversions.
Conclusion: These results of the STAPLE-1 trial document the acute safety
and feasibility of the Aptus Endograft and EndoStaples. Early follow-up
demonstrates excellent 6-month and 1-year results. A pivotal phase II trial
is underway at 25 US centers.Suprarenal aortic cross-clamp position: A reappraisal of its effects on
outcomes for open abdominal aortic aneurysm repair
Tec Chong, Louis Nguyen, Christopher D. Owens, Michael S. Conte, Michael
Belkin
Objectives: With the increasing use of endovascular aneurysm repair,
a greater proportion of open aneurysm repairs in the future are expected
to be more complex and require suprarenal cross-clamping. We sought to
evaluate the effects of suprarenal (SR) vs infrarenal (IR) aortic cross-clamp
position in abdominal aortic aneurysm (AAA) repair in an updated single
center series.
Methods: All elective open AAA repairs performed at our institution
between 1990 and 2006 were entered into a prospective database and re-
viewed retrospectively. Our main stratification variable was SR vs IR. The
SR group was further subdivided into those requiring an adjunctive renal
revascularization procedure (SRþRRP; n = 54) and those who did not
(SRRRP; n = 117). Univariate and multivariate models were used to
analyze the effect of baseline variables and operative variables on our
primary endpoint 30-day mortality as well as secondary endpoints such
as major adverse events, postoperative decline in renal function (defined
as doubling of baseline creatinine to level >2 mg/dL, or new-onset dialysis)
and long-term survival. A propensity score model was developed to control
for confounding variables associated with the use of an SR cross-clamp.
Results: A total of 1020 patients underwent elective AAA repair, of
which 849 (83.2%) were IR and 171 (16.8%) were SR. Diabetes (14.6% vs
9.1%, P = .027), hypertension (70.2% vs 61.4%, P = .03), and chronic renal
failure (14.0% vs 4.7%, P = .001) were more prevalent in the SR group, and
mean aneurysm size was larger (6.0 cm vs 5.6 cm, P = .001). Estimated
blood loss was higher (1919 mL vs 1257 mL, P = .001) in the SR group, as
was mean length of stay (12.6 days vs 10.7 days, P = .047). Perioperative
(30-day) mortality rate was 1.8% for the SR group and 1.2% for the IR group
(P = .44). Postoperative decline in renal function was 17.0% in SR vs 9.5% in
IR (P = .003), however, new-onset dialysis was rare (0.6% SR, 0.8% IR, P = NS).
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erative decline in renal function (14.8% SR+RRP, 4.3% SRRRP, P = .016).
Preoperative renal failure was strongly associated with postoperative renal
decline (odds ratio [OR] 8.15, 2.92-22.8, P < .0001). Propensity score anal-
ysis demonstrated that the use of an SR cross-clamp was associated with
an increased risk for postoperative renal decline (OR 2.66, 1.28-5.50, P =
.009). Major adverse events were more prevalent in the SR group compared
to the IR group (17.0% vs 9.5%, P = .003). Five-year survival was 69.1% + 1.9%
for the IR group and 67.7% + 4.3% for the SR group (P = 0.38) by life table
analysis.
Conclusion: Suprarenal cross-clamping is associated with low mortality and
significant but acceptable morbidity, including postoperative decline in
renal function. The results from this series may serve as relevant background
data when evaluating emerging branched and fenestrated endograft
technologies.Surgical result of critical limb ischemia due to tibial arterial occlusion in
patients with systemic scleroderma
Juno Deguchi, Kunihiro Shigematsu, Satoshi Ota, Hideo Kimura, Masashi
Fukayama, Tetsuro Miyata
Objective: To analyze the outcome after surgery for critical limb ischemia
(CLI) due to tibial artery occlusion in patients with systemic scleroderma.
Methods: The medical records of scleroderma patients with CLI due to tibial
artery occlusion were reviewed with respect to demographic data and peri-
operative variables.
Results: Eight patients were identified at The University of Tokyo Hospital
from 1991 to 2007. The underlying collagen disease was progressive
systemic scleroderma in 6 patients and CREST syndrome in 2 patients.
The subjects were 1 man and 7 women with a mean age of 68 years. While
hypercoagulability including positive anticardiolipin antibodies was found
in only 1 patient, all patients were antinuclear antibody (ANA) positive
and 6 of 8 patients had a high titer of centromere-type ANA. Five under-
went pedal artery bypass and 1 underwent distal peroneal artery bypass,
while 2 underwent primary limb amputation. Although 1 patient with
bypass had early graft occlusion (with subsequent below-knee amputation),
the other 5 patients with patent grafts quickly achieved pain relief and
initial wound healing. However, four of the five patent grafts developed
graft occlusion several months after surgery, with severe intimal thickening
at the anastomosis. As a result, 2 of 6 patients with bypass (totally 4 of 8
patients) underwent limb loss and 1 patient developed persistent recurrent
ulcer.
Conclusion: Bypass surgery in patients with scleroderma and CLI can be
successful in achieving early pain relief and ischemic wound healing.
However, the long-term effectiveness is limited with high rates of graft
failure and limb loss.Outcomes of endoluminal reintervention for restenosis after
percutaneous renal angioplasty and stenting
Mark G. Davies, Wael A. Saad, Jean X. Bismuth, Eric K. Peden, Joseph J.
Naoum, Alan B. Lumsden
Background: Endovascular therapy for symptomatic atherosclerotic renal
artery stenosis (ARAS) is common but is associated with a significant resteno-
sis rate. This study evaluates the outcomes of percutaneous endoluminal
therapy for symptomatic restenosis (>50% on angiography) after renal
intervention.
Methods: We performed a retrospective analysis of records from patients
who underwent endovascular intervention for ARAS and were followed by
duplex ultrasound scan between January 1990 and January 2008. Clinical
benefit defined as freedom from recurrent hypertension or renal-related
morbidity (increase in persistent creatinine >20% of baseline, progression
to hemodialysis, death from renal-related causes), anatomic patency, rest-
enosis, and patient survival were measured.
Results: A total of 447 patients underwent 619 renal artery interventions.
A total of 80 vessels restenosed with an actuarial restenosis rate of 19% at
5 years. Of these restenoses, 65 (81%) were associated with recurrent
symptoms (recurrent hypertension 84%, or continuing deterioration in
renal function 16%). Fifty-five (85%) underwent repeat angioplasty and
10 underwent bypass surgery. The remainder was observed. The 55 percu-
taneous interventions were performed in 51 patients (61% female, averageage 62 years, range, 51-85). A total of 73% had metabolic syndrome, 58%
had hyperlipidemia, and 51% were considered diabetic; all of them had
primary stenting during their first procedure. There was a 4% technical
failure rate in both groups. In the restenosis group, the presence of stent
was associated with a 9% technical failure rate, while in the absence of
a stent the technical failure rate was only 3% (P < .05). At 5 years,
outcomes were equivalent between the primary and recurrent groups
for survival (76  2% vs 75  8%, primary vs recurrent), cumulative
patency (82  3% vs 70  10%), freedom from restenosis (81  3% vs
81  9%), and retained clinical benefit (44  4% vs 46  10%). By Cox
proportional hazards and multivariate analysis, administration of statins
were associated with freedom from restenosis in the recurrent lesions.
Statins, contralateral kidney size (>9 cm) and a 20% improvement in
baseline creatinine with 3 months were associated with freedom from
recurrent symptoms. Restenosis after therapy in recurrent lesions was
significantly correlated with recurrent symptoms (Spearman r = 0.4614,
P < .0004).
Conclusion: Percutaneous reintervention for renal artery restenosis is safe
and effective with equivalent outcomes to primary intervention. The
patients are more likely to present with recurrent hypertension and be
younger and of female gender than patients presenting for primary interven-
tion. Functional outcomes after reintervention are equivalent to primary
intervention.Circumferential and longitudinal cyclic strain of the human thoracic
aorta: Age-related changes
Tina M. Morrison, Gilwoo Choi, Christopher K. Zarins, Charles A. Taylor
Objective: We developed a novel method using anatomic markers along the
thoracic aorta to accurately quantify longitudinal and circumferential cyclic
strain in nondiseased thoracic aortas during the cardiac cycle and to
compute age-related changes of the human thoracic aorta.
Methods: Changes in thoracic aorta cyclic strains were quantified using
cardiac-gated computed tomography image data of 14 patients (aged 35 to
80 years) with no visible aortic pathology (aneurysms or dissection). We
measured the diameter and circumferential cyclic strain in the arch and des-
cending thoracic aorta (DTA), the longitudinal cyclic strain along the DTA,
and changes in arch length and motion of the ascending aorta relative to
the DTA. Diameters were computed distal to the left coronary artery, prox-
imal and distal to the brachiocephalic trunk, and distal to the left common
carotid, left subclavian, and the first and seventh intercostal arteries. Cyclic
strains were computed using the Green-Lagrange strain tensor. Arch length
was defined along the vessel centerline from the left coronary artery to
the first intercostal artery. The length of the DTA was defined along the
vessel centerline from the first to seventh intercostal artery. Longitudinal
cyclic strain was quantified as the difference between the systolic and dia-
stolic DTA lengths divided by the diastolic DTA length. Comparisons were
made between seven younger (age, 41  7 years; 6 men) and seven older
(age, 68  6 years; 6 men) patients.
Results: The average increase of diameters of the thoracic aorta was 14%
with age from the younger to the older (mean age, 41 vs 68 years) group.
The average circumferential cyclic strain of the thoracic aorta decreased
by 55% with age from the younger to the older group. The longitudinal cyclic
strain decreased with age by 50% from the younger to older group (2.0% 
0.4% vs 1.0%  1%, P = .03). The arch length increased by 14% with age from
the younger to the older group (134  17 mm vs 152  10 mm, P = .03).
Conclusions: The thoracic aorta enlarges circumferentially and axially and
deforms significantly less in the circumferential and longitudinal directions
with increasing age. This quantitative description of in vivo longitudinal
cyclic strain and length changes for the human thoracic aorta creates a foun-
dation for standards in reporting data related to in vivo deformation and may
have significant implications in endoaortic device design, testing, and
stability.
Clinical Relevance: Aortic aneurysms remain the 13th leading cause of
death in Western countries, with an incidence of 12.7 cases per 100,000
for thoracic aortic aneurysms (TAA). The ascending aorta is the most
common location for TAA formation, followed by the descending thoracic
aorta and the arch. In contrast to the considerable data that have been ob-
tained on the biomechanical environment of the abdominal aorta, relatively
little is known about the thoracic aorta, healthy or diseased. Data are lack-
ing on wall motion and force data, which affects the design and testing of
stent grafts that are used to treat TAA.
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Lefeng Qu, Dieter Raithel
Precise endograft placement in the thoracic aorta is challenging due to the
special local anatomy and unique hemodynamic blood flow. We are employing
many techniques together to launch the endograft precisely to the target loca-
tion: various debranching techniques to extend the proximal landing zone,
magnified imaging with full exposition of the supra-arch branches and the prox-
imal landing area to achieve a clear and accurate view, screen markers of the
landing target for guidance of deployment, 1-2 cm proximally to the cranial
landingmarkerbefore launching incaseofanydisplacement,steadydeployment
of the endograft in hypotensive status or within the temporary heart asystole
period inducedby intravenousadenosineadministration. If a balloonangioplasty
or a proximal cuff is inevitable, the abovementioned techniques should be
repeated. Our single center results have proved the combined techniques for
precise thoracic endograft placement reliable, effective, simple and practical.Setting up an imaging center, adding CT, MR, and an angiography suite to
vascular labs
Russell H. Samson
Computed tomographic angiography (CTA), magnetic resonance angiography
(MRA), and diagnostic arteriography are all vascular diagnostic tools that
may be included in modern vascular diagnostic laboratories. Before under-
taking the establishment of such an all-purpose diagnostic, and possibly in-
terventional, facility the vascular specialist or group needs to ensure safe
patient care and the ability to provide these diagnostic tests and procedures
without incurring a financial loss. This article will detail one method of
setting up such a facility and suggest some other approaches. It will also
introduce some of the issues that may change the legislative landscape in
the Unites States of America (USA) and may make these arrangements more
complex in that country.
